How to buy Prestige Consumer Healthcare stock

Prestige Consumer Healthcare Inc is a medical distribution business based in the US. Prestige Consumer Healthcare shares (PBH) are listed on the NYSE and all prices are listed in US Dollars. Prestige Consumer Healthcare employs 520 staff and has a trailing 12-month revenue of around 0.00.

Prestige Consumer Healthcare share price

Use our graph to track the performance of PBH stocks over time.

Prestige Consumer Healthcare shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$32.20 - $47.98
50-day moving average	$44.85
200-day moving average	$39.29
Wall St. target price	$47.75
PE ratio	13.9665
Dividend yield	N/A (0%)
Earnings per share (TTM)	$3.28

Buy Prestige Consumer Healthcare shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Prestige Consumer Healthcare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Prestige Consumer Healthcare Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Prestige Consumer Healthcare under- or over-valued?

Valuing Prestige Consumer Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Prestige Consumer Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Prestige Consumer Healthcare's P/E ratio

Prestige Consumer Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Prestige Consumer Healthcare shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Prestige Consumer Healthcare's PEG ratio

Prestige Consumer Healthcare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.5347. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Prestige Consumer Healthcare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Prestige Consumer Healthcare's EBITDA

Prestige Consumer Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $339.5 million.

The EBITDA is a measure of a Prestige Consumer Healthcare's overall financial performance and is widely used to measure a its profitability.

Prestige Consumer Healthcare financials

Revenue TTM	$956.8 million
Operating margin TTM	32.36%
Gross profit TTM	$565.7 million
Return on assets TTM	5.58%
Return on equity TTM	13.41%
Profit margin	17.37%
Book value	$26.51
Market capitalisation	$2.3 billion

TTM: trailing 12 months

Shorting Prestige Consumer Healthcare shares

There are currently 3.2 million Prestige Consumer Healthcare shares held short by investors – that's known as Prestige Consumer Healthcare's "short interest". This figure is 4.3% down from 3.4 million last month.

There are a few different ways that this level of interest in shorting Prestige Consumer Healthcare shares can be evaluated.

Prestige Consumer Healthcare's "short interest ratio" (SIR)

Prestige Consumer Healthcare's "short interest ratio" (SIR) is the quantity of Prestige Consumer Healthcare shares currently shorted divided by the average quantity of Prestige Consumer Healthcare shares traded daily (recently around 350189.44504897). Prestige Consumer Healthcare's SIR currently stands at 9.19. In other words for every 100,000 Prestige Consumer Healthcare shares traded daily on the market, roughly 9190 shares are currently held short.

However Prestige Consumer Healthcare's short interest can also be evaluated against the total number of Prestige Consumer Healthcare shares, or, against the total number of tradable Prestige Consumer Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Prestige Consumer Healthcare's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Prestige Consumer Healthcare shares in existence, roughly 60 shares are currently held short) or 0.0851% of the tradable shares (for every 100,000 tradable Prestige Consumer Healthcare shares, roughly 85 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Prestige Consumer Healthcare.

Find out more about how you can short Prestige Consumer Healthcare stock.

Prestige Consumer Healthcare share dividends

We're not expecting Prestige Consumer Healthcare to pay a dividend over the next 12 months.

Prestige Consumer Healthcare share price volatility

Over the last 12 months, Prestige Consumer Healthcare's shares have ranged in value from as little as $32.195 up to $47.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Prestige Consumer Healthcare's is 0.6933. This would suggest that Prestige Consumer Healthcare's shares are less volatile than average (for this exchange).

Prestige Consumer Healthcare overview

Prestige Consumer Healthcare Inc. , together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc.

Frequently asked questions

• What percentage of Prestige Consumer Healthcare is owned by insiders or institutions?

  Currently 0.888% of Prestige Consumer Healthcare shares are held by insiders and 109.983% by institutions.

• How many people work for Prestige Consumer Healthcare?

  Latest data suggests 520 work at Prestige Consumer Healthcare.

• When does the fiscal year end for Prestige Consumer Healthcare?

  Prestige Consumer Healthcare's fiscal year ends in March.

• Where is Prestige Consumer Healthcare based?

  Prestige Consumer Healthcare's address is: 660 White Plains Road, Tarrytown, NY, United States, 10591

• What is Prestige Consumer Healthcare's ISIN number?

  Prestige Consumer Healthcare's international securities identification number is: US74112D1019

• What is Prestige Consumer Healthcare's CUSIP number?

  Prestige Consumer Healthcare's Committee on Uniform Securities Identification Procedures number is: 74112D101